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Background: Cross-sectional data suggests that a low level of plasma ascorbic acid positively associates with both
Body Mass Index (BMI) and Waist Circumference (WC). This leads to questions about a possible relationship
between dietary intake of ascorbic acid and subsequent changes in anthropometry, and whether such associations
may depend on genetic predisposition to obesity. Hence, we examined whether dietary ascorbic acid, possibly in
interaction with the genetic predisposition to a high BMI, WC or waist-hip ratio adjusted for BMI (WHR), associates
with subsequent annual changes in weight (ΔBW) and waist circumference (ΔWC).
Methods: A total of 7,569 participants’ from MONICA, the Diet Cancer and Health study and the INTER99 study
were included in the study. We combined 50 obesity associated single nucleotide polymorphisms (SNPs) in four
genetic scores: a score of all SNPs and a score for each of the traits (BMI, WC and WHR) with which the SNPs
associate. Linear regression was used to examine the association between ascorbic acid intake and ΔBW or ΔWC.
SNP-score × ascorbic acid interactions were examined by adding product terms to the models.
Results: We found no significant associations between dietary ascorbic acid and ΔBW or ΔWC. Regarding
SNP-score × ascorbic acid interactions, each additional risk allele of the 14 WHR associated SNPs associated with
a ΔWC of 0.039 cm/year (P = 0.02, 95% CI: 0.005 to 0.073) per 100 mg/day higher ascorbic acid intake. However,
the association to ΔWC only remained borderline significant after adjustment for ΔBW.
Conclusion: In general, our study does not support an association between dietary ascorbic acid and ΔBW or ΔWC,
but a diet with a high content of ascorbic acid may be weakly associated to higher WC gain among people who
are genetically predisposed to a high WHR. However, given the quite limited association any public health
relevance is questionable.
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A higher occurrence of nutritional deficiencies among
obese may seem contradictory in light of excess calorie
intake. Nevertheless, micronutrient deficiencies have
been found in obese individuals worldwide, and it has
been suggested that some of these could have an impact
on weight loss [1]. Thus, cross-sectional studies suggest
that a low level of plasma ascorbic acid is associated
with both higher body mass index (BMI) and waist cir-
cumference (WC) [2-4], but prospective data is lacking.
In addition to a cross-sectional relationship, however,
a double blind placebo controlled trial among 38 obese
females demonstrated that supplementation with 3 g
of ascorbic acid per day improved weight loss com-
pared to placebo (2.53 versus 0.95 kg, p = 0.015) during a
6-week period [5]. A possible explanation for this
could be that ascorbic acid is a cofactor in the bio-
synthesis of carnitine, a metabolite necessary for the
oxidation of fatty acids [6]. Consequently, a reduction
in the ability to oxidize fat may be one mechanism
behind the inverse relationship between ascorbic acid
and obesity [7].
Thus, in spite of some indications of associations [2-5]
and plausible biological mechanisms behind [6,7], the
evidence of a causal relationship between intake of
ascorbic acid and subsequent change in body weight
(BW) or WC is weak. One reason for this could be inter-
action with genetic variants, causing ascorbic acid to
mainly play a role in body weight regulation among
individuals with a genetic predisposition to obesity. The
growing number of obesity-associated SNPs identified by
genome wide association studies (GWAS) [8-20] pro-
vides a unique opportunity to investigate this hypothesis.
Hence, the aim of our study was to examine whether
dietary ascorbic acid, possibly in interaction with genetic
predisposition to higher BMI, WC or waist-hip ratio
adjusted for BMI (WHR), associates with annual change




Our study is based on participants from the Danish part
of the MONICA study [21], the Diet, Cancer and Health
(DCH) study [22] and the INTER99 study [23], each of
which are described in the following.
MONICA
This cohort consists of a random subset of 4,581 men
and women born in 1922, 1932 in 1942 and 1952, who
were selected from residents of 11 surrounding munici-
palities in the former Copenhagen County. In 1982–83,
a total of 3,608 (78.8%) of these participants took part in
a health examination, including measurement of BW,height, dietary intake and blood sampling. Five years
later, during 1987–88, another invitation was sent to all
living participants and 2,987 men and women partici-
pated in both the first and second health examinations
[24]. A total of 1,852 participants completed a seven-day
food record in 1982–83 [25], 1,578 of these had complete
information on covariates as well as repeated measures
of BW and 1,426 of these had information on genetic
variants.
For this study, we further excluded participants with
prevalent cancer (n = 16), cardiovascular disease (n = 61)
or self-reported diabetes (n = 20). The final study popula-
tion consisted of 1,329 healthy participants with informa-
tion on diet, genes, baseline and follow-up BW as well as
information on potential confounders.
The diet cancer and health (DCH) study
During 1993–97, a total of 160,725 Danish men and
women living in Copenhagen and Aarhus, between 50
and 64 years of age, born in Denmark and with no
diagnosis of cancer registered in the Danish Cancer
registry were invited to participate in DCH. Of these,
a total of 57,053 (35%) accepted the invitation. These
participants completed a lifestyle questionnaire, and a
192 item semi-quantitative food frequency question-
naire (FFQ) to assess the average intake of food dur-
ing the last year. Furthermore, a follow up study was
conducted during 1999 to 2002 which included self-
administered questionnaires on diet, lifestyle and self-
measured anthropometry.
Data used in this particular study is based on two sam-
ples of 1,200 BW gainers and 1,209 randomly selected
control cohort/sample individuals. These participants
had no cancer, cardiovascular disease or diabetes at
baseline and follow-up, stable smoking habits, an annual
weight gain not more than 5 kg/year, age <60 years at
baseline and <65 years at follow-up. BW gainers were
defined as the individuals who experienced the greatest
degree of annual weight gain during follow-up. They
were identified in gender stratified analysis by using the
residuals from a regression model of ΔBW on baseline
values of age, BW and height, smoking status (current/
former/never smokers), and follow-up time. From these
models, a total of 600 male and 600 female BW gainers
were selected. The random sample was based on the
complete cohort. The overlap between BW gainers and
random sample was small (n = 79), thus the size of the
remaining (non-overlapping) random sample (n = 1,130)
almost equaled the number of weight gainers (12). Of
the 2,330 individuals, we had information on diet, genes,
changes in anthropometry and selected covariates on
2,167 men and women (2,128 in the analysis of ΔWC).
However, 278 of these only had information on FTO
(rs9939609).
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A population-based randomized controlled trial
(CT00289237, ClinicalTrials.gov) initiated in 1999. This
year, an age- and sex- stratified random sample of 13,016
men and women born in 1939–40, 1944–45, 1949–50,
1954–55, 1959–60, 1964–65, 1969–70, living in 11 muni-
cipalities in the former Copenhagen County was drawn
from the Civil Registration System and invited to a health
examination. Of the 13,016 participants, a total of 12,934
were eligible for invitation, and, of these, 6,784 (52.5%)
participated. Dietary intake was assessed through FFQ
[26]. Design and methods used in the study have been
described in detail elsewhere [23,27]. In 2004, all par-
ticipants from the baseline examination were re-invited
for a follow-up study where the baseline examination
programme was repeated [28]. Information on diet, genes,
baseline and follow-up anthropometric measures as well
as information on potential confounders was available on
4,574 subjects. For the present study, we excluded par-
ticipants with prevalent cancer (n = 87), cardiovascular
disease (n = 320) or self-reported diabetes (n = 94) and
ended up with 4,073 participants (3,536 participants in the
analysis of ΔWC).
All procedures in the three studies were in accordance
with the Helsinki Declaration and all participants pro-
vided written informed consent.
Assessment of dietary intake
As described in detail elsewhere, information about the
participants' dietary intake was collected using a validated
seven-day food record in MONICA [25] and the same
validated FFQ in DCH [29,30] and INTER99 [26]. From
this information, daily consumption of foods and nutrients
were calculated for each participant using the software
program DANKOST [31] in MONICA and FoodCalc [32]
in DCH and INTER99. Both DANKOST and FoodCalc
are based on the official Danish food composition tables
(http://www.foodcomp.dk). Participants' daily intake of as-
corbic acid was then calculated and included in the
analysis as a continuous variable (unit; mg/day).
Assessment of covariates
All participants reported information on smoking status
(never smoked, ex-smoker or current smoker). Likewise,
information was gathered about consumption of alcohol
and included in the analysis as a continuous variable
(MJ/day). Regarding physical activity, the MONICA par-
ticipants were asked to classify themselves into one of
four groups 1) Almost completely inactive: sedentary
activities such as reading, watching television and going
to the movies. 2) Some physical activity: at least 4 hours
weekly including for example walking, cycling, construc-
tion work, bowling and table tennis. 3) Regular hard
activity at least 3 hours weekly, including for exampleswimming, tennis and badminton etc. or heavy garden-
ing. 4) Hard activity: elite sports such as swimming, soc-
cer, badminton or long distance running several times a
week. In DCH the questionnaire was used to obtain
information on duration and types of physical activity.
From this information the validated Cambridge Physical
Activity Index was calculated by combining occupational
physical activity with time spent on cycling and sport in
summer and winter [33]. Participants were then divided
into four physical activity categories (inactive, moderately
inactive, moderately active, and active). In INTER99 infor-
mation on physical activity was based on two questions on
commuting physical activity and leisure time physical
activity. From these two questions, overall physical activity
was calculated by summing response on commuting phys-
ical activity (converted into minutes per week using five
day working week) and a leisure time physical activity
variable (converted into minutes per week) [28]. From this
variable, overall physical activity was grouped into four
categories <2 h/week, 2–3.9 h/week, 4–6.9 h/week and
≥7 h/week. Education was assessed with questions about
years of regular schooling in all three cohorts and clas-
sified with respect to having a school education above or
below the primary level. Finally, we included information
on the participants’ age and gender, and the women
reported whether they had entered menopause.
Assessment of anthropometric measures
At baseline, height was measured to the nearest 0.5 cm
and BW to the nearest 0.1 kg in all three cohorts. Like-
wise, WC was measured horizontally midway between
the lower rib margin and the iliac crest to the nearest
1 cm in DCH and INTER99. We did not have measures
of WC on enough participants to include this measure
in the analysis of the MONICA participants.
At follow-up, the baseline procedure was repeated for
MONICA and INTER99 participants. Regarding the
follow-up measures in DCH, the participants received a
self-administrated questionnaire and reported their
weight (kg) and WC (cm) measured at the level of the
umbilicus using an enclosed paper measuring tape. A
validation study was performed on 408 participants to
compare measures of waist circumference obtained by
technicians and by self-report, which showed that the
self-reported WC at the level of the umbilicus was highly
correlated with the technician-measured WC at the nat-
ural WC. The Spearman’s correlation coefficient was 0.87
in men and 0.88 in women [34].
From this information, we calculated change in BW as
the difference between measures during 1982–83 and
1987–88 for MONICA, and change in BW and WC
during 1993–97 and 1999–2002 for DCH and during
1999–2001 and 2004–06 for INTER99. From this we
calculated ΔBW and ΔWC in each cohort by dividing
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time in years.
SNP selection and genotyping
Through review of GWAS, we found 63 SNPs associated
to different obesity related phenotypes [8-20,35,36], and 58
of these SNPs were consistently associated with BMI, WC
or WHR [8-20]. In the present study, we included SNPs
that were available in all three cohorts. Hence, we ended
up with a total of 50 SNPs (Additional file 1: Table S1).
In MONICA and DCH, the SNPs were genotyped with
the KASPar SNP Genotyping method. In MONICA,
they had an average genotyping success rate of 98.3%
(minimum 95.8%). In DCH, the average genotyping
success rate was 97.8% and 185 replicate samples had a
success rate above 98% and an error rate below 0.5%.
Finally, in INTER99 the SNPs were successfully
genotyped using either the KASPar SNP Genotyping
method, or through Human Cardio-metabo bead chip
array (2 SNPs; rs7138803 and rs7647305) using Illu-
mina Hi-Scan technology and GenomeStudio software
(http://www.illumina.com/systems/hiscan.ilmn). The aver-
age genotyping success rate for the INTER99 study was
96.7% (minimum 94.7).
Genetic predisposition scores
For each subject, the 50 SNPs were coded 0, 1 or 2
according to number of obesity associated risk alleles.
Four different SNP-scores were then calculated as indi-
cators of genetic predisposition: A score of all 50 SNPs
(range: 0 to 100), 33 BMI associated SNPs (range: 0 to 66),
6 WC associated SNPs (range: 0 to 12) and 14 WHR asso-
ciated SNPs (range: 0 to 28), with higher scores indicating
higher genetic predisposition to these specific traits.
Statistical analysis
Linear regression was used to examine the association
between dietary ascorbic acid and subsequent ΔBW and
ΔWC. First in a crude model with adjustments only for
height and baseline measure of outcome, and then in a
fully adjusted model where we also included age, sex,
smoking status, education level, physical activity, meno-
pausal status and alcohol consumption. Furthermore, to
assess associations that were independent of ΔBW, the
analysis with ΔWC as outcome was performed both with
and without adjustment for concurrent ΔBW. The same
procedure was applied using each of the four SNP-
scores as the exposure variable. All continuous variables
were evaluated by model control (investigating linearity
of effects on used outcomes, consistency with a normal
distribution and variance homogeneity).
To examine interaction between the four genetic
predisposition scores and dietary ascorbic acid in relation
to ΔBW or ΔWC, we correspondingly added the SNP-score variables as well as the interaction terms (SNP-
score × ascorbic acid). After performing the analysis in the
individual cohorts, the results were combined in a meta-
analysis. We performed both fixed- and random effect
models. The effect-estimates from the individual cohorts
were weighted based on the inverses of their variances.
Heterogeneity between the studies was assessed by so
called Q tests and I2-values, where the latter measure indi-
cates the amount of total variation explained by between-
study variation [37] and was evaluated according to the
following categories: no heterogeneity, I2: 0–25%; moder-
ate heterogeneity, I2: 25–50%; significant heterogeneity, I2:
50–75%; and extreme heterogeneity, I2: 75–100%. Since
the Q-tests showed no significant heterogeneity and the
calculated I2-values were all below 50% we only presented
results from the fixed effect models. Furthermore, results
from the random effect models were almost identical to
those from the fixed effect models.
Finally, with exploratory purposes, we performed the
analysis of interactions between the 50 individual SNPs
and dietary ascorbic acid in relation to ΔBW and ΔWC,
with Bonferroni adjustment for multiple testing.
Supplementary analyses
To further limit the possibility of confounding by energy
intake, we performed supplementary analyses where we
adjusted for total energy intake. Finally, in DCH we had
information about intake of ascorbic acid from supple-
ments, and in MONICA we had information on intake
of multivitamins. Hence, in supplementary analyses we
also adjusted for these variables.
As described, the DCH participants included in the
present study consist of both a sample of BW gainers
and a random sample. To maximize the study's statistical
power, we decided to include both groups. However, we
also performed separate analyses for the two groups.
Furthermore, INTER99 is a multifactorial lifestyle inter-
vention, where the intervention group received a lifestyle
counseling talk focusing on smoking, physical activity, diet
and alcohol. Hence, in supplementary analyses, we further
adjusted the INTER99 analyses for baseline intervention
status.
P-values ≤ 0.05 were regarded as statistically signifi-
cant. All analyses were performed using the statistical




For this study we had information on 1,329 individuals
from MONICA, 2,167 from DCH and 4,073 from the
INTER99 study. Table 1 shows characteristics of an-
thropometrics, genetic predisposition scores, intake of
dietary ascorbic acid and information on covariates in the
Table 1 Ascorbic acid intake, anthropometrics, SNP-scores and covariates in MONICA, DCH and INTER99
MONICA DCH INTER99
N 1,329 2,167 4,073
Basic variables
Ascorbic acid (mg/day) 70 (23 to 199) 93 (43 to 207) 66 (25 to 156)
Baseline age (years) 50.5 (30.6 to 61.1) 53.0 (50.0 to 58.0) 45.1 (34.7 to 59.8)
Sex (% women) 51.6 49.4 51.4
Height (cm) 169 (156 to 184) 171 (158 to 186) 172 (158 to 188)
BW (kg)
Baseline 69.0 (52.0 to 93.0) 77.1 (56.8 to 104.4) 75.5 (55 to 104)
Follow-up 70.0 (51.6 to 94.7) 82.0 (58.0 to 110.0) 76.5 (55.6 to 105.0)
ΔBW 0.22 (−1.04 to 1.61) 1.01 (−1.05 to 2.39) 0.20 (−1.41 to 1.75)
WC (cm)1
Baseline - 90 (70 to 112) 85 (67 to 107)
Follow-up - 98 (76 to 121) 88 (69 to 110)
ΔWC - 1.37 (−0.78 to 4.44) 0.55 (−1.27 to 2.46)
SNP-based variables2
SNP-score (BMI) 29 (23 to 35) 28 (23 to 35) 29 (23 to 34)
SNP-score (WC) 3 (1 to 6) 3 (1 to 6) 3 (1 to 6)
SNP-score (WHR) 14 (10 to 18) 14 (10 to 18) 14 (10 to 18)
SNP-score (complete) 44 (37 to 52) 44 (37 to 51) 44 (36 to 51)
Adjustment variables
Smoking, % Never smokers 27 41.4 40.1
Education, %≤ Primary school 35.7 30.1 26.2
Physical activity, % most sedentary group 21.4 9.5 11.5
Menopausal status, % postmenopausal 42.4 55.6 27.5
Total energy intake excl. alcohol, (MJ/day) 8.5 (4.8 to 13.9) 8.2 (4.9 to 13.4) 9.0 (4.9 to 15.1)
Alcohol (MJ/day) 0.4 (0 to 1.8) 0.4 (0 to 1.9) 0.3 (0 to 1.5)
Abbreviations: BW body weight, WC waist circumference, ΔBW annual weight change, ΔWC annual WC change.
1DCH: n = 2,165 on baseline WC, n = 2,130 on follow-up WC and n = 2,128 on ΔWC. INTER99: n = 4,067 on baseline WC, n = 3,540 on follow-up WC and n = 3,536
on ΔWC.
2Sum of BMI, WC or WHR associated risk-alleles. In MONICA information was available in n = 989 on BMI SNP-score, n = 1,250 on WC SNP-score, n = 1,185 on WHR
SNP-score and n = 878 on complete SNP-score. In DCH n = 1,438 on BMI SNP-score, n = 1,805 on WC SNP-score, n = 1,624 on WHR SNP-score and n = 1,247 on
complete SNP-score. In INTER99 n = 2,511 on BMI SNP-score, n = 3,381 on WC SNP-score, n = 3,264 on WHR SNP-score, n = 2,082 on complete score.
Results presented as median (5–95 percentiles) unless otherwise stated.
Larsen et al. Nutrition Journal 2014, 13:43 Page 5 of 11
http://www.nutritionj.com/content/13/1/43three cohorts. In relation to measures of BW and WC,
both the baseline values and annual gains were highest
among the DCH participants because of the case-cohort
design. The median dietary intake of ascorbic acid was
70 mg/day (5-95% percentiles: 23 to 199) among MONICA
participants, 93 mg/day (5-95% percentiles: 43 to 207)
among DCH participants and 66 mg/day (5-95% percen-
tiles: 25 to 156) among INTER99 participants.
The genetic predisposition scores were nearly identical
in terms of median and 5-95% percentiles in all three
cohorts. Since there was not complete information on
all the included SNPs, the sample size varies slightly
depending on what SNP-score we included. The score
consisting of all 50 SNPs (n: MONICA = 878, DCH =
1,247, INTER99 = 2,082), the score of 33 BMI associatedSNPs (n: MONICA = 989, DCH = 1,438, INTER99 =
2,511), the score of 6 WC associated SNPs (n: MONICA =
1,250, DCH = 1,805, INTER99 = 3,381) and the score
of 14 WHR associated SNPs (n: MONICA = 1,185,
DCH = 1,624, INTER99 = 3,264).
Dietary ascorbic acid in relation to change in weight and
waist circumference
The cross-sectional associations between dietary ascor-
bic acid and BW or WC are presented in Additional file 1:
Table S2. We did not find a statistically significant associ-
ation between baseline ascorbic acid and BW. However,
after adjusting for potential confounders we found a sig-
nificantly lower WC of −0.64 cm (p = 0.03, CI −1.22
to −0.05) per 100 mg/day ascorbic acid.
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ΔBW as well as ΔWC is presented in Table 2 for both
the crude and the adjusted models. The result from the
meta-analysis of the crude model showed a ΔBW of
−0.048 kg (P = 0.03, CI: −0.092 to −0.004) per 100 mg/day
higher ascorbic acid. However, after adjusting for potential
confounders, the result from the meta-analysis was not
statistically significant with a ΔBW of −0.014 (P = 0.54,
CI: −0.059 to 0.031). Likewise, we found no statistically
significant association between dietary ascorbic acid
and ΔWC.
Genetic predisposition scores in relation to weight and
waist circumference
The “main effects” of the four SNP-scores have been
published elsewhere [38]. Since the scores are based on
SNPs identified through cross sectional GWAS, we
generally observed statistically significant associations
with BW and WC at baseline, with the exception of the
WHR-score. However, when analyzing the associations
between our four SNP-scores and subsequent changes in
BW and WC, neither the crude nor the adjusted models
showed any statistically significant associations [38].
Interaction between genetic predisposition scores and
dietary ascorbic acid
In Figure 1, the results on SNP-score × ascorbic acid
interactions are presented in relation to ΔBW. The fig-
ure shows the association between ascorbic acid and
ΔBW per additional risk allele from each of the four
SNP-scores. In the meta-analysis, we found no signifi-
cant interactions between any of the four SNP-scores
and dietary ascorbic acid in relation to the subsequent
change in BW. However, we did find a tendency towards
an interaction between the score of 33 BMI associatedTable 2 Annual change in body weight (kg) and waist circum
in the three cohorts
N Crude β (95% CI)1
Annual weight change (kg)
MONICA 1,329 −0.024 (−0.097 to 0.049)
DCH 2,167 −0.103 (−0.192 to −0.015
INTER99 4,073 −0.035 (−0.106 to 0.035)
Overall 7,569 −0.048 (−0.092 to −0.004
Annual waist change (cm)
DCH 2,128 −0.119 (−0.246 to 0.007)
INTER99 3,536 −0.010 (−0.098 to 0.079)
Overall 5,664 −0.046 (−0.118 to 0.027)
1Adjusted for baseline outcome and height.
2Adjusted for baseline outcome, height, sex, age, smoking status, alcohol consumpt
with change in waist circumference adjusted for concurrent weight change.
3Estimates were calculated in MONICA, DCH and INTER99 using linear regression an
were weighted based on the inverses of their variances (% weight).SNPs and ascorbic acid in relation to ΔBW. Each add-
itional risk allele from this score was associated with an
average ΔBW effect-modification of −0.013 kg/year
(P = 0.08, 95% CI: −0.027 to 0.002) per 100 mg/day
higher ascorbic acid intake.
To further investigate this tendency, we looked at the
association between ascorbic acid and ΔBW in tertiles of
the BMI associated SNP-score (Additional file 1: Figure S1).
Using this approach, we found no statistically significant
association between ascorbic acid and ΔBW in any of the
tertiles.
Figure 2 shows the results on SNP-score × ascorbic
acid interactions in relation to ΔWC. In the meta-analysis,
we found no statistically significant interactions between
the scores of BMI or WC associated SNPs and dietary
ascorbic acid. However, we found an interaction between
the score of 14 WHR associated SNPs and ascorbic acid.
In the meta-analysis, each additional risk allele was
associated with an average ΔWC effect-modification
of 0.039 cm/year (P = 0.02, 95% CI: 0.005 to 0.073) per
100 mg/day higher ascorbic acid intake. After adjusting
for ΔBW, the tendency in the direction of the association
persisted, but was not statistically significant (Additional
file 1: Figure S2).
We further looked at the association between ascorbic
acid and ΔWC in tertiles of the WHR associated
SNP-score, both with and without adjustment for ΔBW
(Additional file 1: Figure S3). Using this procedure, we
found no statistically significant association between
ascorbic acid and ΔWC in any of the tertiles.
Finally, we investigated interaction between the individ-
ual SNPs and ascorbic acid in relation to ΔBW (Additional
file 1: Table S3) and ΔWC (Additional file 1: Table S4).
After adjusting for multiple testing none of the results were
statistically significant.ference (cm) pr. 100 mg/day higher ascorbic acid intake
% weight3 Adjusted β (95% CI)2 % weight
36.38 −0.018 (−0.093 to 0.057) 36.84
) 24.71 −0.082 (−0.172 to 0.009) 25.11
38.91 0.035 (−0.039 to 0.108) 38.05
) 100 −0.014 (−0.059 to 0.031) 100
32.82 −0.111 (−0.219 to 0.003) 26.28
67.12 0.010 (−0.074 to 0.055) 73.72
100 −0.034 (−0.089 to 0.021) 100
ion, physical activity, education and menopausal status for women. Analysis
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Figure 1 Interaction between genetic predisposition scores and dietary ascorbic acid in relation to change in body weight. Abbreviations:
BMI score, sum of body mass index associated risk-alleles; WC score, sum of waist circumference associated risk-alleles; WHR score, sum of waist-hip
ratio associated risk-alleles; Complete score, sum of SNP associated to all three phenotypes. Results presented as annual weight change (kg/year)
effect-modification for each additional risk-allele per 100 mg/day higher ascorbic acid intake. The study-specific SNP-score × ascorbic acid interactions
were calculated using linear regression and corresponding meta-analysis results were derived using a fixed effect approach, where the effect-estimates
where weighted by the inverses of their variances (% weight). The results were adjusted for baseline measure of body weight, height, sex, age,
smoking status, alcohol consumption, physical activity, education and menopausal status for women.
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Additional adjustment for total energy had virtually no
influence on the observed associations. Likewise, further
adjustment for ascorbic acid from supplements in DCH,
and multivitamin supplements in MONICA, had negli-
gible influence on the observed associations.
As described, the sample from the DCH cohort consists
of a group of weight gainers and a group of randomly
selected participants. Hence, we further performed ana-
lyses separately for the two groups. However, neither
results on main effect of ascorbic acid in relation to
change in ΔBW or ΔWC nor results on interaction with
genetic predispositions scores, showed any statistically
significant difference between the two groups.
Furthermore, in INTER99 we adjusted for baseline
intervention status, and this did not change the direction
or the statistical significance of the reported results.
Discussion
Using data from three cohorts of 7,569 Danish men and
women, we found no statistically significant association
between ascorbic acid intake and ΔBW or ΔWC in gen-
eral. Likewise, although the four SNP-scores generally
showed strong associations to baseline anthropometrythey did not associate to change in these measures. We
did, however, find a statistically significant interaction
between a score of 14 WHR-associated SNPs and dietary
ascorbic acid in relation to ΔWC, suggesting that dietary
ascorbic acid may be associated to a higher gain in WC
among people genetically predisposed to a high WHR.
However, the WHR-score × ascorbic acid interactions in
relation to ΔWC was only borderline significant, after
adjustment for concurrent ΔBW. Furthermore, we found
a tendency towards an interaction between a score of 33
BMI-associated SNPs and dietary ascorbic acid. This
interaction suggested that intake of ascorbic acid may be
associated with a lower subsequent BW gain among
people who are genetically predisposed to a high BMI.
Finally, we found no statistically significant interactions
in relation to ΔBW using scores of SNPs associated with
WC, WHR or the sum of all 50 obesity associated SNPs.
Likewise, we found no statistically significant interac-
tions in relation to ΔWC using scores of BMI, WC or
the sum of all 50 obesity associated SNPs.
The main strengths of our study include the detailed
measures of dietary information collected either with
7-day food records or FFQs along with repeated mea-
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Figure 2 Interaction between genetic predisposition scores and dietary ascorbic acid in relation to change in waist circumference.
Abbreviations: BMI score, sum of body mass index associated risk-alleles; WC score, sum of waist circumference associated risk-alleles; WHR score,
sum of waist-hip ratio associated risk-alleles; Complete score, sum of SNP associated to all three phenotypes. Results presented as annual change
in waist circumference (cm/year) for each additional risk-allele per 100 mg/day higher ascorbic acid intake. The study-specific SNP-score × ascorbic
acid interactions were calculated using linear regression and corresponding meta-analysis results where derived using a fixed effect approach,
were the effect-estimates were weighted by the inverses of their variances (% weight). The results were adjusted for baseline measure of waist
circumference, height, sex, age, smoking status, alcohol consumption, physical activity, education and menopausal status for women.
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SNPs selected based on their consistent cross-sectional
association with obesity related traits, allowing us to cal-
culate genetic predisposition scores. Despite the fact that
the sum of these variants only explain very little of the
total variation in these measures of adiposity (<5%) this
has become one of the favored methods to study gene ×
environment interactions in relation to obesity [39,40].
However, our study also has some limitations. Regard-
less of the method used to collect dietary data, these
methods are generally subject to inaccuracies. In addition,
dietary content of ascorbic acid is highly dependent on
how the food has been prepared [41] and stored [42], and
although preparation of the food has been taken into
account when nutrient calculations were performed, this
could affect the accuracy of our exposure measure. Hence,
measurement error related to dietary intake could have
biased the results towards null and led to wider confi-
dence intervals.
Furthermore, dietary intake of ascorbic acid is not
necessarily a good indicator of the biological status, and
therefore measures of serum ascorbic acid would have
strengthened the study. Also, we do not know with
certainty whether the results of our study are directly
caused by ascorbic acid or other common factors of a
diet with a high content of this specific nutrient. Hence,
dietary ascorbic acid may be an indicator of a particulardietary pattern and lifestyle, and it is possible that some
of these factors account for the observed associations
and not the actual nutrient per se. It has been suggested
that consumption of fruit and vegetables, which is the
primary source of ascorbic acid, is weakly associated to
BW loss [43]. Hence, associations observed in our study
could also be due to other characteristics of this food
group, such as a high content of dietary fiber and flavo-
noids. Furthermore, contrary to our expectations, dietary
ascorbic acid appeared to be associated to a higher WC
gain among those who were genetically predisposed to a
high WHR. In this context, an important argument is
that we consume ascorbic acid from a wide variety of
foods. Hence, a possible explanation for our results
could be that the genetically predisposed prefer to con-
sume ascorbic acid from other dietary sources than the
less predisposed. Hence, we do not know whether our
results actually indicate a different effect of ascorbic acid
on changes in WC depending on the genetic predis-
position, or whether the results are an expression of
different dietary preferences between genetic subgroups.
Thus, the observed results should be interpreted with
caution.
Finally, studies of specific dietary nutrients, as well as
studies on genetic variants in relation to obesity, have
generally shown relatively weak associations. Hence, it is
likely that the size of any SNP × calcium interactions is
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might be too small to discover potential SNP × calcium
interactions. As a result, it is possible that we have over-
looked some associations due to lack of statistical power.
However, the interaction estimates generally had very
narrow confidence intervals, suggesting it is unlikely that
we have overlooked large associations. In addition, the
size of the statistically significant interaction observed in
our study was very small, indicating that we had suffi-
cient statistical power to measure an association so small
that any public health relevance is doubtful.
The majority of published studies examining the asso-
ciations between ascorbic acid and BW or WC have
been cross-sectional [2-4,44] and although these studies
find that low ascorbic acid status is associated with
higher BW or WC they do not shed light on a possible
causal relationship. However, Naylor et al. (1985) pub-
lished results from a double blind placebo controlled
trial of 38 obese subjects. In this study, they demon-
strated that supplementation with 3 g of ascorbic acid
per day increased weight loss compared to placebo dur-
ing a 6-week period [5]. Moreover, studies have shown
that mice fed on a high fat diet supplemented with
ascorbic acid gained less adipose tissue than their non-
supplemented controls [45,46].
In our study, we were unable to find a significant asso-
ciation between dietary ascorbic acid and subsequent
change in BW. One possible explanation for the different
results in our study and these previous studies is that
supplementation with high doses of ascorbic acid may
lead to other biological effects than dietary intake. In
addition, due to a higher oxidative stress status, it is
possible that the relationship is primarily present among
obese individuals or people eating a high fat diet [45].
It has been proposed that ascorbic acid may decrease
BW and WC through a contribution to production of
the amino acid carnitine, which is required in the oxida-
tion of fatty acids [7]. Whether these or other biological
mechanisms depend on genetic predisposition to high
BMI, WHR or WC is speculative due to the limited
knowledge about the biological implications of the inclu-
ded genetic variants.
Finally, it should be taken into account that the partici-
pants included in our study were not necessarily represen-
tative of the general Danish adult population. Especially,
participants from the DCH sample of which half was a
selected group of weight gainers. Furthermore, partici-
pants in the three cohorts have a healthier lifestyle than
the general Danish population. Consequently, generaliza-
tions from our results should be made with caution.
Conclusions
Our study does not suggest that dietary ascorbic acid is
generally related to ΔBW or ΔWC. However, a diet highin ascorbic acid may be associated with a slightly higher
WC gain among people genetically predisposed to a high
WHR. Nevertheless, the associations were generally weak
and inconsistent. Hence, further replications are needed
before final conclusions regarding these associations can
be reached.
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